Celgene Corp. buy melinda
Start price
11.10.13
/
50%
€56.45
Target price
23.12.13
€60.00
Performance (%)
9.27%
End price
23.12.13
€61.68
Summary
This prediction ended on 23.12.13 with a price of €61.68. With a performance of 9.27%, the BUY prediction by melinda for Celgene Corp. closed with a slight gain. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Celgene Corp. | - | - | - | - |
| iShares Core DAX® | 1.001% | -1.218% | 13.263% | 60.023% |
| iShares Nasdaq 100 | -1.447% | -4.597% | 0.414% | 85.321% |
| iShares Nikkei 225® | 8.406% | 8.425% | 27.328% | 61.038% |
| iShares S&P 500 | -0.226% | -2.451% | 0.167% | 57.738% |
Comments by melinda for this prediction
In the thread Celgene Corp. diskutieren
erhöhen
RBC Capital Markets
(Vom Mitglied beendet)


